Simplifying the complexity of resistance heterogeneity in metastasis

about

Niche inheritance: a cooperative pathway to enhance cancer cell fitness through ecosystem engineering.The impact of cell density and mutations in a model of multidrug resistance in solid tumors.Modeling the Dynamics of Heterogeneity of Solid Tumors in Response to Chemotherapy.

P2860

Q34086276-CA23D384-4A33-4890-9DF7-B21395547F26 Q36692520-A73784B0-10E1-41D3-958F-6FB35BFA8D72 Q47653913-2625810B-1D02-40D2-BEF2-DE8FF458A0C5

P2860

Simplifying the complexity of resistance heterogeneity in metastasis

Item

http://www.wikidata.org/entity/Q37655188

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Simplifying the complexity of resistance heterogeneity in metastasis

@en

Simplifying the complexity of resistance heterogeneity in metastasis.

@nl

type

Item

label

Simplifying the complexity of resistance heterogeneity in metastasis

@en

Simplifying the complexity of resistance heterogeneity in metastasis.

@nl

prefLabel

Simplifying the complexity of resistance heterogeneity in metastasis

@en

Simplifying the complexity of resistance heterogeneity in metastasis.

@nl

P1476

Simplifying the complexity of resistance heterogeneity in metastasis

@en

P2093

Doron Levy

http://www.w3.org/2001/XMLSchema#string

James M Greene

http://www.w3.org/2001/XMLSchema#string

Michael M Gottesman

http://www.w3.org/2001/XMLSchema#string

Orit Lavi

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.

The growth law of primary breast cancer as inferred from mammography screening trials data.

Tumor growth rates derived from data for patients in a clinical trial correlate strongly with patient survival: a novel strategy for evaluation of clinical trial data.

Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance

Tumor regression and growth rates determined in five intramural NCI prostate cancer trials: the growth rate constant as an indicator of therapeutic efficacy.

Tumor hypoxia and genetic alterations in sporadic cancers.

Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantage.

Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growth.

The dynamics of drug resistance: a mathematical perspective

Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives

P304

129-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLMED.2013.12.005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260090322

http://www.w3.org/2001/XMLSchema#string

P698

24491979

http://www.w3.org/2001/XMLSchema#string

P932

3962236

http://www.w3.org/2001/XMLSchema#string

Simplifying the complexity of resistance heterogeneity in metastasis

about

P2860

P2860

Simplifying the complexity of resistance heterogeneity in metastasis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932